EASL launches major new funding initiative at ILC 2017

By EASL May 16,2017

In a keynote speech given at the International Liver Congress in Amsterdam, world-renowned hepatologist, Professor Massimo Colombo launched the EASL International Liver Foundation (EASL-ILF).

The audience of over 8,000 professionals were informed on how the Foundation will fund and support innovative research, nurture the new generation of liver scientists and mobilize the necessary knowledge and best practices in liver health. The Foundation will deliver dedicated fund-raising and strategic assistance to scientists, clinicians, and educators around the world.

EASL-ILF is building partnerships and driving collaborations with patients, civil society, governments and the private sector.

Established in Geneva, Switzerland the Foundation is now actively fundraising and supporting projects. “The more money we raise, the more we can help people turn science into doing,” said Foundation CEO, Stefano Gnes. He continued. “We invite anyone interested in making a difference in liver health to join us and support our efforts.” 

Initiatives include: 

  1. Micro-elimination of HCV
  2. Development of large scale public awareness campaigns around screening and prevention of liver disease
  3. Fostering an evidence-based approach in the assessment of hepatic risks associated with occupational & environmental exposures
  4. Educational outreach and capacity building activities

All current and future initiatives aim to deliver on the Foundation’s mission statement: “Everyone deserves a healthy liver”.

Professor Colombo summarized the goals of the Foundation “We will measure the Foundation’s success not simply in financial terms, but in the number of innovations, ideas and initiatives it brings to life.”

To learn more about the EASL International Liver Foundation, visit the website.